You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The Effect of Intravenous Vitamin C on Cancer- and Chemotherapy-Related Fatigue and Quality of Life
|
|---|---|
| Published in |
Frontiers in oncology, October 2014
|
| DOI | 10.3389/fonc.2014.00283 |
| Pubmed ID | |
| Authors |
Anitra C. Carr, Margreet C. M. Vissers, John S. Cook |
| Abstract |
Cancer patients commonly experience a number of symptoms of disease progression and the side-effects of radiation therapy and adjuvant chemotherapy, which adversely impact on their quality of life (QOL). Fatigue is one of the most common and debilitating symptom reported by cancer patients and can affect QOL more than pain. Several recent studies have indicated that intravenous (IV) vitamin C alleviates a number of cancer- and chemotherapy-related symptoms, such as fatigue, insomnia, loss of appetite, nausea, and pain. Improvements in physical, role, cognitive, emotional, and social functioning, as well as an improvement in overall health, were also observed. In this mini review, we briefly cover the methods commonly used to assess health-related QOL in cancer patients, and describe the few recent studies examining the effects of IV vitamin C on cancer- and chemotherapy-related QOL. We discuss potential mechanisms that might explain an improvement in QOL and also considerations for future studies. |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 25% |
| Canada | 3 | 19% |
| Peru | 1 | 6% |
| Spain | 1 | 6% |
| United Kingdom | 1 | 6% |
| Unknown | 6 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 75% |
| Practitioners (doctors, other healthcare professionals) | 4 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Portugal | 1 | <1% |
| Colombia | 1 | <1% |
| Germany | 1 | <1% |
| Canada | 1 | <1% |
| Denmark | 1 | <1% |
| Unknown | 155 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 26 | 16% |
| Student > Master | 19 | 12% |
| Researcher | 18 | 11% |
| Other | 16 | 10% |
| Student > Doctoral Student | 13 | 8% |
| Other | 29 | 18% |
| Unknown | 39 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 65 | 41% |
| Nursing and Health Professions | 15 | 9% |
| Agricultural and Biological Sciences | 8 | 5% |
| Biochemistry, Genetics and Molecular Biology | 8 | 5% |
| Psychology | 6 | 4% |
| Other | 17 | 11% |
| Unknown | 41 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 62. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2023.
All research outputs
#689,026
of 25,373,627 outputs
Outputs from Frontiers in oncology
#113
of 22,416 outputs
Outputs of similar age
#7,253
of 268,229 outputs
Outputs of similar age from Frontiers in oncology
#1
of 97 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,416 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 268,229 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.